The document discusses the Drug Technical Advisory Board (DTAB), which consists of 18 members including 8 ex-officio members, 5 nominated members, and 5 elected members. Key positions include the Director General of Health Services as chairman and representatives from various medical and pharmaceutical organizations. The document also highlights the process of member nominations and elections by relevant councils and committees.